BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Niu H, Yang P, Ma J, Yuan BY, Zeng ZC, Xiang ZL. Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients. BMC Cancer 2021;21:161. [PMID: 33588789 DOI: 10.1186/s12885-021-07808-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yuan X, Zhuang M, Zhu X, Cheng D, Liu J, Sun D, Qiu X, Lu Y, Sartorius K. Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma. Front Oncol 2022;12:943866. [DOI: 10.3389/fonc.2022.943866] [Reference Citation Analysis]
2 Moonmuang S, Chaiyawat P, Jantrapirom S, Pruksakorn D, Lo Piccolo L. Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma. Cancers 2021;13:4214. [DOI: 10.3390/cancers13164214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Barik GK, Sahay O, Behera A, Naik D, Kalita B. Keep your eyes peeled for long noncoding RNAs: Explaining their boundless role in cancer metastasis, drug resistance, and clinical application. Biochim Biophys Acta Rev Cancer 2021;1876:188612. [PMID: 34391844 DOI: 10.1016/j.bbcan.2021.188612] [Reference Citation Analysis]
4 Huang Z, Wen J, Wang Y, Han S, Li Z, Hu X, Zhu D, Wang Z, Liang J, Liang H, Chen X, Zhang B. Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives. Front Med . [DOI: 10.1007/s11684-022-0928-z] [Reference Citation Analysis]